Home

Henry Ji

CIK 1470981 · Exec Chair, CEO and President · last filed 2026-04-20

Henry Ji is an Exec Chair, CEO and President who has filed 64 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for SCLXW, was dated Apr 20, 2026. Across all open-market trades the lifetime net is +$1.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $35.5K across reported positions. 62 SEC filings were submitted jointly with Sorrento Therapeutics, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$35.5K

Companies

2

Total Filings

64

Lifetime Open-Market Net

$1.93M

Filer Profile

Reported Address
5370 RUETTE DE MER
SAN DIEGO, CA 92130
Related Filers
Sorrento Therapeutics, Inc. — 62 joint filings, latest 2023-03-20
Scilex Holding Co — 11 joint filings, latest 2026-04-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCLXW Exec Chair, CEO and President 322,910 $0.11 $35.5K $62.0K 9 2026-04-20
Sorrento Therapeutics, Inc. (SRNE) Delisted See Remarks 6,305,805 $0.00 $3.2K $1.87M 43 2022-12-23

Recent Filings

64 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-20 SCLXW Mixed — $0 EDGAR
2025-10-09 SCLXW Grant (A) — $0 EDGAR
2024-10-31 SCLXW Buy (P) +8,888 $8.4K EDGAR
2024-10-18 SCLXW Buy (P) +10,000 $9.7K EDGAR
2024-06-18 SCLXW Exer (M) +6,000 $8.5K EDGAR
2024-05-17 SCLXW Buy (P) +50,000 $44.0K EDGAR
2023-10-05 SCLXW Grant (A) — $0 EDGAR
2023-03-20 SCLXW Other (J) +2,730 $23.5K EDGAR
2023-03-20 — Mixed +19,500 $15.7K
2023-01-17 SCLXW Grant (A) — $0 EDGAR
Showing 1–10 of 64
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.